Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
73 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Peninsula Oncology Centre
Frankston, Victoria, Australia
- Sir Charles Gairdner Hospital
Perth, Western Australia, Australia
- Chris O'Brien Lifehouse at Rpa
Camperdown, Australia
- Monash Cancer Center
East Bentlrigh, Australia
- Epworth Hospital
Melbourne, Australia
- Northern Cancer Institute
Sydney, Australia
- Calvary Mater Newcastle
Waratah, Australia
- Princess Alexandra Hospital +61(0)7 3176 5054
Woolloongabba, Australia
- Ucl - St. Luc
Brussels, Belgium
- Antwerp University Hospital
Edegem, Belgium
- University Hopsital Ghent
Ghent, Belgium
- Universitaire Ziekenhuizen Leuven (university Hospitals Leuven)
Leuven, Belgium
- Chu Liege - Sart Tilman
Liège, Belgium
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Chru, Lille
Lille, France
- Hôpitaux de Marseille
Marseille, France
- Gustave Roussy
Villejuif, France
- Cliniche Humanitas Gavazzeni
Bergamo, Italy
- Istituto Oncologico Veneto
Padova, Italy
- Kyushu Cancer Center
Fukuoka, Japan
- Hiroshima University Hospital
Hiroshima, Japan
- Hyogo College of Medicine
Hyōgo, Japan
- Okayama Rousai Hospital
Okayama, Japan
- Kinki University Hospital
Osaka, Japan
- Juntendo University
Tokyo, Japan
- Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis
Amsterdam, Netherlands
- Medisch Spectrum Twente, Enschede
Enschede, Netherlands
- Atrium Mc
Heerlen, Netherlands
- Erasmus Mc
Rotterdam, Netherlands
- Auckland Oncology Research Centre
Auckland, New Zealand
- Canterbury Regional Cancer & Haematology Service
Christchurch, New Zealand
- Norwegian Radium Hospital
Oslo, Norway
- Centrum Pulmonologii Ii Torakochirurgii W Bystrej
Bystra, Poland
- Iatros International / Bloemfontein Medi-Clinic
Bloemfontein, Free State, South Africa
- the Medical Oncology Centre of Rosebank
Johannesburg, South Africa
- Mary Potter Oncology Center, Little Company of Mary Hospital
Pretoria, South Africa
- Institut Oncològic del Vallés Consorci Hospitalari Parc Tauli
Barcelona, Spain
- Vall D'Hebron University Hospital
Barcelona, Spain
- Ensayos Clínicos Oncología
Madrid, Spain
- Hospital Madrid Norte- Sanchinarro, Centro Integral Oncológico Clara Campal (ciocc)
Madrid, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2013
- Primary completion
- 31 Jan 2016
- Completion
- 31 Jan 2016
- Last update posted
- 30 Jan 2017
- Registered enrollment
- 344
- Registry id
- NCT01870609
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.